Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it has appointed R. Alberto Avendano, M.D., as the Company’s Chief Medical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE